| Literature DB >> 33857169 |
Ketlin Jaquelline Santana Castro1, Railson Cruz Salomão2, Newton Quintino Feitosa2, Leonardo Dutra Henriques3, Ana Francisca Rozin Kleiner4, Anderson Belgamo5, André Santos Cabral6, Anselmo Athayde Costa E Silva7, Bianca Callegari7,8, Givago Silva Souza1,2.
Abstract
We investigated the impact of visual impairment on balance control. We measured the center of pressure (COP) between the two feet and plantar surface pressures on each foot in 18 normal-sighted participants and compared their data with measures from 18 legally blind participants, either acquired or congenital. Pressures were measured in open- and closed-eye conditions using a baropodometric resistive plate. In the eyes-open condition, there were no differences between the sighted and legally blind groups in COP displacement. However, participants with visual loss had significantly increased pressures in two metatarsal regions (M1 and M2 zones) of the plantar surface in both viewing conditions (p < 0.05). The differences in pressure measures between the normally sighted and legally blind groups could be attributed mainly to the subgroup of subjects with acquired impairment. Our findings suggest that subjects with visual impairment present increased metatarsal pressures (i.e. forefoot), not yet associated to anterior displacement of COP or impaired balance control.Entities:
Year: 2021 PMID: 33857169 PMCID: PMC8049300 DOI: 10.1371/journal.pone.0249467
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Description of the visual deficits of the visually impaired participants.
| Patient | Diagnosis | Blindness | Visual acuity |
|---|---|---|---|
| P1 | Glaucoma | Congenital | LP/LP |
| P2 | Optic nerve atrophy | Acquired (10 years ago) | LP/LP |
| P3 | Glaucoma | Congenital | HM 1.7’/CF 1.7’ |
| P4 | Pituitary adenoma | Acquired (17 years ago) | NLP/NLP |
| P5 | Cataract | Acquired (5 years ago) | LP/LP |
| P6 | ND | Congenital | NLP/NLP |
| P7 | ON atrophy | Acquired (13 years ago) | LP/LP |
| P8 | Uveitis | Congenital | NLP/NLP |
| P9 | Cataract | Congenital | LP/LP |
| P10 | Cataract | Acquired (2 years ago) | LP/LP |
| P11 | Cataract | Congenital | LP/LP |
| P12 | Chorioretinitis | Acquired (30 years ago) | 20/200/CF 3.5’ |
| P13 | ND | Congenital | LP/LP |
| P14 | Retinitis pigmentosa | Congenital | LP/LP |
| P15 | Glaucoma | Congenital | LP/LP |
| P16 | Glaucoma | Acquired (8 years ago) | NLP/NLP |
| P17 | Cataract | Congenital | LP/LP |
| P18 | Glaucoma | Acquired (3 years ago) | LP/LP |
ND: not diagnosed; ON: Optic neuritis; LP: Light perception; NLP: No light perception; CF: Counting fingers; HM: Hand motion. The visual acuity descriptions for counting fingers or hand motion are expressed as the maximum distance, in feet, from which detection was successful.
Physical characteristics of the groups.
| Variable | CG | VIG | p-value |
|---|---|---|---|
| Age (years) | 31.8 ± 8.3 | 31.5 ± 9.4 | 0.90 |
| BMI (kg/cm2) | 25.4 ± 4.4 | 24.8 ± 5.1 | 0.73 |
| Male/Female | 12 M/ 6 F | 13 M/ 5 F | 0.99 |
Values are present as means and standard deviations for age and BMI.
CG: control group; VIG: visually impaired group; BMI: body mass index.
Fig 1Representation of the zones of the foot where plantar pressures were quantified.
Forefoot is represented by the T1 (first toe), T2-5 (2nd-5th toes), M1 (1st metacarpal), M2 (2nd metacarpal), M3 (3rd metacarpal), M4 (4th metacarpal), M5 (5th metacarpal) zones; Midfoot is represented by the MF zone; Hindfoot is represented by the medial (MH) and lateral zones (LH).
Fig 2Statokinesiogram of one representative participant from the sighted group and one representative participant from the blind group.
Recordings from the sighted participant in the open-eye (A) and closed-eye condition (B), and from a visually impaired (blind) participant in the open-eye (C) and closed-eye (D) conditions.
Comparison of stabilometric data obtained from control and visually impaired groups.
| Variable | CG | LBG | P |
|---|---|---|---|
| COPdistance | 327.46 (93) | 311.23 (89.2) | 0.99 |
| COParea | 87.69 (72.6) | 68.33 (61.9) | 0.86 |
| COPdistance | 351.3 (48.3) | 319.75 (101.9) | 0.42 |
| COParea | 110.64 (109.1) | 73.66 (58.8) | 0.5 |
CG: control group; LBG: legally blind group.
Comparison of the stabilometric parameters between control group and visually impaired group according to etiology of the impairment.
| Legally blind group | ||||
|---|---|---|---|---|
| Variable | Control group | Congenital | Acquired | p-value |
| COPdistance | 327.5 (103.8) | 345.8 (140.1) | 309.3 (75.2) | 0.93 |
| COPárea | 87.7 (82.1) | 69.03 (63.5) | 66.82 (112.4) | 0.84 |
| COPdistance | 351.3 (57) | 336.6 (165.1) | 317.7 (50.3) | 0.53 |
| COParea | 110.6 (118.6) | 66.59 (102.91) | 92.04 (120.1) | 0.43 |
Fig 3Heatmap of the plantar pressure measurements obtained from the participants whose balance control data are shown in Fig 2.
(A) Sighted participant. The pressures are distributed from the hallux to mid-lateral foot and in the heel. (B) Visually impaired participant. The pressure distribution occurs mainly in the hallux, all the metatarsal region of the left foot and in the heel.
Comparison of Pmean and Pmax measured in the different foot regions of control and visually impaired participants.
| T1 | 6.83 (13.2) | 10.92 (13.8) | 0.27 | 8.83 (14.4) | 14.33 (13.5) | 0.67 |
| T2-5 | 3.17 (4.9) | 5.16 (4.5) | 0.12 | 3.75 (6.3) | 5.58 (6.1) | 0.32 |
| M1 | ||||||
| M2 | 27.08 (21.5) | 33.75 (21.3) | 0.12 | 27.33 (20.3) | 34.25 (21.7) | 0.06 |
| M3 | 40.75 (21.7) | 43.25 (19.6) | 0.41 | 35.92 (19.9) | 45.75 (24.9) | 0.15 |
| M4 | 43.92 (26.8) | 48 (19.6) | 0.44 | 39.5 (28) | 46.5 (20.4) | 0.87 |
| M5 | 24 (24.7) | 29.42 (13.6) | 0.99 | 26.17 (22.5) | 26.25 (13.8) | 0.56 |
| MF | 11.58 (11) | 13.83 (9.1) | 0.12 | 12.33 (11.6) | 14.83 (8.3) | 0.3 |
| MH | 63.92 (18) | 59.17 (18) | 0.5 | 60.92 (22) | 60.67 (22.2) | 0.8 |
| LH | 63.17 (10.1) | 57.83 (13.3) | 0.36 | 59.42 (15.8) | 56.17 (19.7) | 0.83 |
| T1 | 16.5 (43.8) | 30 (44.4) | 0.19 | 22.08 (51.8) | 44.5 (41.1) | 0.63 |
| T2-5 | 6.5 (14.2) | 10.92 (17.3) | 0.2 | 7.67 (17.5) | 14.25 (20.6) | 0.3 |
| M1 | 49.17 (29.8) | 60.83 (41.3) | 0.06 | |||
| M2 | ||||||
| M3 | 85.75 (46.7) | 89.25 (38.1) | 0.56 | 73.33 (40.4) | 90.17 (42.8) | 0.37 |
| M4 | 87 (58.2) | 90.92 (41.6) | 0.94 | 79.08 (52.1) | 86.83 (44.6) | 0.97 |
| M5 | 69.75 (67.9) | 82 (37) | 0.94 | 74.92 (62.8) | 72.42 (38.9) | 0.75 |
| MF | 36.17 (36.2) | 39.25 (12.5) | 0.59 | 41.92 (42.1) | 38.5 (18.3) | 0.63 |
| MH | 153.3 (38.8) | 145.3 (36.5) | 0.37 | 148.4 (39.2) | 153.8 (55.6) | 0.97 |
| LH | 149 (33.5) | 141.9 (30.5) | 0.41 | 140.8 (40.9) | 146.9 (53.1) | 0.96 |
CG: Control group; LBG: Legally blind group. Comparisons in bold represent significant differences using a Mann-Whitney test.
Comparison of the plantar pressures among controls, congenital and acquired visually impaired participants during eye aperture conditions.
| T1 | 6.83 (13.2) | 9.25 (13.9) | 13.5 (10.6) | 8.83 (14.4) | 8.58 (15) | 15.67 (9.8) |
| T2-5 | 3.17 (4.9) | 4.25 (3) | 7.08 (8) | 3.75 (6.33) | 4.33 (7.2) | 7.08 (4.7) |
| M1 | 18.25 (9.2) | 25.75 (16) | 25.08 (20.2) | 18.08 (6) | 23.08 (12.2) | |
| M2 | 27.08 (21.5) | 33.67 (18.2) | 34.83 (25.3) | 27.33 (20.3) | 34.25 (18) | 36.92 (23.1) |
| M3 | 40.75 (21.7) | 43.25 (23.9) | 42 (23.7) | 35.92 (19.9) | 40.67 (25.08) | 49.08 (29.6) |
| M4 | 43.92 (26.8) | 46.83 (25.5) | 47.67 (24.6) | 39.5 (28) | 42.42 (25) | 48.67 (21.8) |
| M5 | 24 (24.7) | 30.17 (10.9) | 27.25 (18) | 26.17 (22.5) | 26.42 (19.5) | 25.58 (11.8) |
| MF | 11.58 (11) | 13.5 (9.9) | 14.33 (10.3) | 12.3 (11.5) | 12.3 (18.4) | 16.42 (4.9) |
| MH | 63.92 (18) | 59.42 (19.4) | 57.83 (18.8) | 60.92 (21.7) | 61.17 (24.8) | 58.67 (19.2) |
| LH | 60.75 (11.7) | 57.83 (14.6) | 57.83 (20.5) | 59.42 (15.8) | 57.67 (26.1) | 53.92 (16.3) |
| T1 | 17.58 (57.5) | 23.83 (44.7) | 43 (35.2) | 22.08 (51.8) | 25.42 (48.3) | 48.92 (27.5) |
| T2-5 | 6.5 (14.2) | 8.83 (9.4) | 18.75 (32.8) | 7.67 (17.5) | 8.58 (19) | 20.67 (19.8) |
| M1 | 49.17 (29.8) | 63.92 (44.4) | 65.83 (58.3) | 43.5 (19.7) | 59.25 (29.6) | 70.33 (52.5) |
| M2 | 62.25 (38.7) | 81.42 (36.3) | 78.83 (43.7) | 58.83 (35.5) | 75.25 (35.3) | |
| M3 | 85.75 (46.7) | 90.42 (44.6) | 85.25 (46.7) | 73.33 (40.4) | 79.42 (45) | 96.58 (52.5) |
| M4 | 87 (58.2) | 87.67 (47.4) | 96 (49.6) | 79.08 (52.1) | 82.5 (47) | 94.25 (57.2) |
| M5 | 69.75 (67.9) | 82 (37.7) | 78.58 (49.7) | 74.92 (62.7) | 71.67 (46.5) | 74.67 (34.8) |
| MF | 36.17 (36.2) | 41.25 (24) | 46.75 (25.8) | 41.92 (42.1) | 36.33 (47.9) | 43.17 (17.2) |
| MH | 153.3 (38.8) | 155.7 (33.8) | 134.3 (52.9) | 148.4 (39.2) | 158.4 (58.1) | 139.8 (45.8) |
| LH | 149 (33.5) | 150.5 (31.7) | 135.9 (50.5) | 140.8 (40.9) | 150.3 (52.3) | 135.2 (45.2) |
Comparisons in bold represent significant differences using Kruskal-Wallis test followed by Dunn’s post hoc test.
*Higher than the control group (Dunn’s test, p = 0.02).
**Higher than the control group (Dunn’s test, p = 0.04).